Oprah Winfrey will not seek reelection to the board of WW International, known as WeightWatchers.
It was a surprising time to jump on board — WeightWatchers had been shedding users, and its stock price was dwindling.
AdvertisementDespite not naming the brand, there was an immediate spike in demand for GLP-1 medications — the popular new class of weight-loss drugs.
That same day, WW added a weight-loss drug arm to its business, acquiring Sequence, a service that provides weight-loss drugs.
AdvertisementLong-term, WW needs to find a new identityOver time, WW will benefit from being a purveyor of hard-to-access weight-loss drugs.
Persons:
Oprah Winfrey, —, Oprah giveth, Oprah taketh, maven, Winfrey, — WeightWatchers, Axios, Oprah, Forbes, Craig, Alex Fuhrman, Winfrey's, We're, Atkins
Organizations:
WW International, Service, SEC, Guardian, People Magazine, MarketWatch, Mayo Clinic, Business, Smithsonian's National Museum of, CNBC, Slate
Locations:
GLP, WeightWatchers